SCHEMBL10913619

SCHEMBL10913619

O=C(O)CN1CCCCCC(N[C@@H](CCc2ccccc2)C(=O)O)C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACE P12821 11/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10914793 1.00 ACE (1.00) ACE
SCHEMBL10894142 1.00 ACE (1.00) ACE
SCHEMBL10913621 1.00 ACE (1.00) ACE
SCHEMBL10913634 1.00 ACE (1.00) ACE
SCHEMBL10795877 0.99 ACE (1.00) ACE
SCHEMBL10942260 0.99 ACE (1.00) ACE
SCHEMBL10795873 0.99 ACE (1.00) ACE
SCHEMBL10914686 0.94 ACE (0.88) ACE
SCHEMBL10792401 0.93 ACE (0.88) ACE
SCHEMBL10792409 0.93 ACE (0.88) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4587050-A Substituted enantholactam derivatives as antihypertensives MERCK & CO., INC. (US) 1986-05-06 US disclosed
EP-0046289-A2 Substituted enantholactam derivatives as antihypertensives, a process for preparing and a pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed